[144] RINGCENTRAL, INC. SEC Filing

Rhea-AI Filing Summary

RingCentral, Inc. (RNG) filing a Form 144 to report a proposed sale of 2,598 shares of common stock through Morgan Stanley Smith Barney LLC at an aggregate market value of $79,576.74. The filing lists the approximate sale date as 09/11/2025 and the securities exchange as NYSE. The shares were acquired on 09/01/2025 as Restricted Stock Units granted by the issuer, with payment/settlement dated 09/01/2025. The filing also discloses three prior sales over the past three months made under 10b5-1 arrangements by Tarun Arora: 4,032 shares on 08/29/2025 for $123,866.27, 1,037 shares on 08/26/2025 for $32,240.33, and 7,776 shares on 06/27/2025 for $217,730.06. The filer affirms no undisclosed material adverse information and includes the standard Rule 10b5-1/attestation language.

Positive

• Disclosure includes specific acquisition details: shares were acquired as Restricted Stock Units on 09/01/2025, providing clear provenance of the shares
• Use of established broker: proposed sale routed through Morgan Stanley Smith Barney LLC, indicating orderly execution
• Prior 10b5-1 sales disclosed: three recent 10b5-1 transactions are listed with dates and gross proceeds, showing consistent adherence to prearranged plans

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; modest share amount and recent acquisition as RSUs suggest standard compensation-related disposition.

The Form 144 reports a proposed disposal of 2,598 common shares of RingCentral on NYSE via Morgan Stanley Smith Barney, with the shares acquired as Restricted Stock Units on 09/01/2025. The aggregate value reported is $79,576.74, a de minimis amount relative to a large-cap issuer. The filing also documents multiple 10b5-1 sales by the same individual in the prior three months, indicating use of prearranged plans. For investors, this appears administrative and compensation-driven rather than a signal of company-specific trouble, given the small absolute size and the RSU origin of the shares.

Compliance / Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 and 10b5-1 attestation; filing contains necessary acquisition and sale-history details.

The submission includes required elements: broker identity, number of shares, acquisition date and nature (RSUs), and prior 10b5-1 sales with gross proceeds. The signer attests to no undisclosed material adverse information and references plan adoption/instruction language, satisfying typical compliance expectations. Absent additional context on holder identity beyond prior-sale listing, the filing is a standard, properly formatted notice of proposed sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2598	79576.74	80738182	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2025	Restricted Stock Units	Issuer			2598	09/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for TARUN ARORA 20 Davis Drive Belmont CA 94002	Common	08/29/2025	4032	123866.27
10b5-1 Sales for TARUN ARORA 20 Davis Drive Belmont CA 94002	Common	08/26/2025	1037	32240.33
10b5-1 Sales for TARUN ARORA 20 Davis Drive Belmont CA 94002	Common	06/27/2025	7776	217730.06

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the RingCentral (RNG) Form 144?

The Form 144 reports a proposed sale of 2,598 RingCentral common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $79,576.74 and an approximate sale date of 09/11/2025.

How were the 2,598 RingCentral shares acquired?

The shares were acquired on 09/01/2025 as Restricted Stock Units (RSUs) from the issuer, with the payment/settlement date shown as 09/01/2025.

Does the filing show prior sales by the same person?

Yes. The filing lists three 10b5-1 sales by Tarun Arora: 7,776 shares on 06/27/2025 for $217,730.06, 1,037 shares on 08/26/2025 for $32,240.33, and 4,032 shares on 08/29/2025 for $123,866.27.

Through which exchange and broker will the sale occur?

The proposed sale lists the NYSE as the securities exchange and Morgan Stanley Smith Barney LLC as the broker.

Does the filer certify anything about material information?

Yes. By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 plan adoption/instruction language.